Carr 3 Km 8 3 Ave 65th Infanteria Box 6021, Carolina, PR, 00984 · (787) 757-1800
Beds
212
FY 2025
Star rating
Not rated
Overall rating
Net patient revenue
$64.5M
FY 2025
Net income
$3.4M
Patient care margin -7.6%
Discharges
9,148
Occupancy 70.3%
Clinicians
66
Medicare clinicians who work here
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $64.5M | $69.4M | -7.6% | $3.4M | 9,148 | $5.4M | 7.6% | 39.3% |
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
| Hospital-wide death rate within 30 days | 8.1% | US median 3.9% |
| Death rate for stroke patients | 24.5% | US median 11.6% |
| Readmission rate for COPD | 20% | US median 19.8% |
| Readmission rate after a heart attack | 16.1% | US median 14.4% |
| Readmission rate for heart failure | 24.6% | US median 21.3% |
| Readmission rate after hip or knee replacement | 5.2% |
Medicare clinicians who list this hospital, by specialty
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| Carl Zeiss Meditec USA, Inc. | 1 | $753 |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
| 2024 | $62.2M | $63.2M | -1.7% | $5.4M | 8,989 | $160K | 7.0% | 36.8% |
| 2023 | $54.8M | $60.3M | -9.9% | $752K | 8,682 | $3.4M | 6.8% | 39.5% |
| 2022 | $52.9M | $53.6M | -1.5% | $6.0M | 8,045 | $170K | 7.6% | 41.3% |
| 2021 | $46.6M | $47.1M | -1.2% | $20.5M | 7,039 | $256K | 9.3% | 34.4% |
| 2020 | $49.8M | $52.1M | -4.7% | $133K | 7,468 | $2.0M | 9.6% | 38.9% |
| US median 5.8% |
| Readmission rate for pneumonia | 19.3% | US median 17.2% |
| Complications after hip or knee replacement | 3.2% | US median 4.1% |
| Central line bloodstream infections (ratio to expected) | 0.36 | US median 0.48 |
| Catheter urinary tract infections (ratio to expected) | 0.00 | US median 0.40 · better |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 1% | US median 15% |
| Patients who got appropriate care for severe sepsis and septic shock | 36% | US median 65% |
Hospital Upr, Dr Federico Trilla is a nonprofit short-term acute care hospital in Carolina, PR with 212 beds.
Hospital Upr, Dr Federico Trilla in Carolina, PR has 212 beds (fiscal year 2025 cost report); 250 beds are certified for Medicare. It discharged 9,148 inpatients that year, with 70.3% of its beds in use on average.
In fiscal year 2025 (ending 2025-06-30), Hospital Upr, Dr Federico Trilla reported net patient revenue of $64.5M and operating expenses of $69.4M, a margin on patient care of -7.6%. After other income and expenses its net income was $3.4M (4.6% of revenue), so it made a profit that year.
Hospital Upr, Dr Federico Trilla is not part of a multi-hospital health system in the official ownership records. It is a nonprofit hospital (Nonprofit (private)).
Hospital Upr, Dr Federico Trilla has no overall star rating, usually because it reports too few quality measures (for example small, specialty or federal hospitals).
Yes, Hospital Upr, Dr Federico Trilla provides emergency services.
66 Medicare clinicians list Hospital Upr, Dr Federico Trilla as a hospital they work at, most often in Internal Medicine, Emergency Medicine, Nephrology.
In 2023, companies reported $753 in payments to Hospital Upr, Dr Federico Trilla as a teaching hospital ($753 general and - for research) from 1 companies.